发布求助
文献互助 智能选刊 最新文献

Current Opinion in Pulmonary Medicine最新文献

筛选
英文 中文
Lung abscess: an update on the current knowledge and call for future investigations. 肺脓肿：现有知识的更新和未来研究的呼吁。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-02-19 DOI: 10.1097/MCP.0000000000001058
Søren Sperling, Victor Naestholt Dahl, Andreas Fløe
{"title":"Lung abscess: an update on the current knowledge and call for future investigations.","authors":"Søren Sperling, Victor Naestholt Dahl, Andreas Fløe","doi":"10.1097/MCP.0000000000001058","DOIUrl":"10.1097/MCP.0000000000001058","url":null,"abstract":"<p><strong>Purpose of review: </strong>Lung abscess is a severe and complex respiratory infection. The purpose of this review is to discuss recent publications on lung abscess, covering topics such as epidemiology, clinical presentation, diagnosis, and treatment and prevention.</p><p><strong>Recent findings: </strong>Risk factors associated with lung abscess include structural lung disease, poor dental hygiene, and ventilator-associated pneumonia, while concerns are now raised regarding the potential of electronic cigarettes use as a risk factor. The complexity of lung abscess is reflected by the relative high number of case reports describing rare and complex cases. Early transthoracic drainage could improve in-hospital outcomes, while next-generation sequencing could become an important tool in diagnostics and future clinical studies.</p><p><strong>Summary: </strong>High-quality evidence and guidelines to support treatment of lung abscess are lacking. Despite advancements, we call for prospective studies to evaluate the use of invasive procedures and antibiotic treatment regimens.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"229-234"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic. 生物制剂时代导致哮喘恶化的病毒感染和 COVID-19 大流行。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-02-26 DOI: 10.1097/MCP.0000000000001061
Pedro A Lamothe, Violeta Capric, F Eun-Hyung Lee
{"title":"Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic.","authors":"Pedro A Lamothe, Violeta Capric, F Eun-Hyung Lee","doi":"10.1097/MCP.0000000000001061","DOIUrl":"10.1097/MCP.0000000000001061","url":null,"abstract":"<p><strong>Purpose of review: </strong>Asthma exacerbations are associated with substantial symptom burden and healthcare costs. Viral infections are the most common identified cause of asthma exacerbations. The epidemiology of viral respiratory infections has undergone a significant evolution during the COVID-19 pandemic. The relationship between viruses and asthmatic hosts has long been recognized but it is still incompletely understood. The use of newly approved asthma biologics has helped us understand this interaction better.</p><p><strong>Recent findings: </strong>We review recent updates on the interaction between asthma and respiratory viruses, and we address how biologics and immunotherapies could affect this relationship by altering the respiratory mucosa cytokine milieu. By exploring the evolving epidemiological landscape of viral infections during the different phases of the COVID-19 pandemic, we emphasize the early post-pandemic stage, where a resurgence of pre-pandemic viruses with atypical seasonality patterns occurred. Finally, we discuss the newly developed RSV and SARS-CoV-2 vaccines and how they reduce respiratory infections.</p><p><strong>Summary: </strong>Characterizing how respiratory viruses interact with asthmatic hosts will allow us to identify tailored therapies to reduce the burden of asthma exacerbations. New vaccination strategies are likely to shape the future viral asthma exacerbation landscape.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"287-293"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remission in asthma. 哮喘缓解
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-05 DOI: 10.1097/MCP.0000000000001068
Marek Lommatzsch
{"title":"Remission in asthma.","authors":"Marek Lommatzsch","doi":"10.1097/MCP.0000000000001068","DOIUrl":"10.1097/MCP.0000000000001068","url":null,"abstract":"<p><strong>Purpose of review: </strong>To review the current concepts of remission in asthma.</p><p><strong>Recent findings: </strong>Until 2023, asthma guidelines have been promoting the concept of disease control, recommending the step-wise addition of drugs until the best possible disease control is achieved. With the advent of highly effective, anti-inflammatory disease-modifying antiasthmatic drugs (DMAADs), treatment goals of asthma have changed. Several national guidelines have now announced remission as a general treatment goal in asthma. Currently, all guidelines agree that asthma remission is defined by the presence of at least three characteristics over a period of at least one 1 year: absence of exacerbations, no systemic corticosteroid use for the treatment of asthma and minimal asthma-related symptoms. In the future, a generally accepted, evidence-based and easy-to-use definition of remission will be needed for daily clinical practice. It is clear, however, that precise phenotyping (including measurement of biomarkers) is an essential prerequisite to achieve clinical remission in each individual patient.</p><p><strong>Summary: </strong>Remission has been included as the treatment goal in asthma in several national guidelines, reflecting the paradigm shift in asthma, from short-term symptom control to long-term symptom prevention. An international consensus on the criteria for asthma remission is expected in the near future.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"325-329"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10990011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140027623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asthma in pregnancy: a review of recent literature. 妊娠期哮喘：最新文献综述。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-13 DOI: 10.1097/MCP.0000000000001072
Kelly Colas, Jennifer Namazy
{"title":"Asthma in pregnancy: a review of recent literature.","authors":"Kelly Colas, Jennifer Namazy","doi":"10.1097/MCP.0000000000001072","DOIUrl":"10.1097/MCP.0000000000001072","url":null,"abstract":"<p><strong>Purpose of review: </strong>Asthma remains the most common respiratory disease in pregnancy. Identifying risk factors for asthma exacerbations during pregnancy is critical, as uncontrolled asthma can have detrimental effects for both mother and baby. In this review, we discuss recent literature exploring risk factors, fetal and maternal effects, and treatment options for asthma during pregnancy.</p><p><strong>Recent findings: </strong>Recent literature suggests that optimizing asthma during pregnancy improves outcomes for both mother and baby, as well as later in childhood. Current research affirms that the benefit of asthma medication use outweighs any potential risks related to the medications themselves. Limited information is available regarding the use of newer therapies such as biologics during pregnancy.</p><p><strong>Summary: </strong>Identifying risk factors for asthma exacerbations during pregnancy is critical to prevent adverse outcomes for both mother and baby. Recent evidence continues to affirm the safety of asthma medication use; more studies are needed regarding the use of new therapies during pregnancy.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"313-324"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140109547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculous pleuritis: clinical presentations and diagnostic challenges. 结核性胸膜炎：临床表现和诊断难题。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-02-06 DOI: 10.1097/MCP.0000000000001052
Ken Ka Pang Chan, Yun Chor Gary Lee
{"title":"Tuberculous pleuritis: clinical presentations and diagnostic challenges.","authors":"Ken Ka Pang Chan, Yun Chor Gary Lee","doi":"10.1097/MCP.0000000000001052","DOIUrl":"10.1097/MCP.0000000000001052","url":null,"abstract":"<p><strong>Purpose of review: </strong>Tuberculous pleuritis (TBP) is one of the most common types of extrapulmonary tuberculosis. We highlight the latest epidemiology of TBP, the heterogeneity of its presentation and the performance of different diagnostic strategies.</p><p><strong>Recent findings: </strong>There are differential trends in the incidences of TBP worldwide. Its incidence increased in China but decreased in the United States in the past decade. The presentation of TBP is heterogeneous regarding clinical symptoms, radiological findings and pleural fluid analysis results. Conventional microbiological tests have low sensitivities to diagnose TBP. Recent research focused on various diagnostic tools with better yield. The sensitivity of nucleic acid amplification tests (NAAT) in pleural fluid, including the latest generation of PCR and sequencing-based techniques for detecting tuberculosis, remains suboptimal. Various pleural fluid biomarkers have been explored, but there is a lack of consensus on their clinical utility and cutoff levels.</p><p><strong>Summary: </strong>The heterogeneity of clinical presentation poses obstacles to diagnosing TBP. Further development of diagnostic tools, including more robust NAAT and biomarkers with additional validation, is needed before incorporation into routine clinical practice.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"210-216"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10990028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139697126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management. 耐多药结核病：关于流行病学、快速诊断和管理的最新观点。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-15 DOI: 10.1097/MCP.0000000000001070
Peter S Nyasulu, Cheick Oumar Doumbia, Veranyuy Ngah, Antieme Combo Georges Togo, Bassirou Diarra, Gershom Chongwe
{"title":"Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management.","authors":"Peter S Nyasulu, Cheick Oumar Doumbia, Veranyuy Ngah, Antieme Combo Georges Togo, Bassirou Diarra, Gershom Chongwe","doi":"10.1097/MCP.0000000000001070","DOIUrl":"10.1097/MCP.0000000000001070","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review addresses the escalating global challenge of multidrug-resistant tuberculosis (MDR-TB) in Sub-Saharan Africa, with a focus on its complex comorbidity with HIV/AIDS. Emphasizing the urgency of the issue, the review aims to shed light on the unique healthcare landscape shaped by the convergence of high prevalence rates and intersecting complexities with HIV/AIDS in the region.</p><p><strong>Recent findings: </strong>A notable increase in MDR-TB cases across Sub-Saharan Africa is attributed to challenges in timely diagnoses, treatment initiation, and patient treatment defaulting. The literature underscores the critical need for proactive measures to address diagnostic and treatment gaps associated with MDR-TB, particularly concerning its comorbidity with HIV/AIDS.</p><p><strong>Summary: </strong>To effectively manage MDR-TB and its co-morbidity with HIV/AIDS, proactive screening programs are imperative. The review highlights the necessity of active follow-up strategies to ensure treatment adherence and reduce default rates, offering evidence-based insights for improved disease management in the region.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"217-228"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11095862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent developments in occupational asthma. 职业性哮喘的最新进展。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-02-28 DOI: 10.1097/MCP.0000000000001062
Claudia Blouin, Catherine Lemière
{"title":"Recent developments in occupational asthma.","authors":"Claudia Blouin, Catherine Lemière","doi":"10.1097/MCP.0000000000001062","DOIUrl":"10.1097/MCP.0000000000001062","url":null,"abstract":"<p><strong>Purpose of review: </strong>Occupational asthma (OA) is a complex condition that can be difficult to diagnose. The purpose of this review is to describe some recent findings regarding the epidemiology of OA, the occupational sensitizing agents, the prognosis of OA, and its primary prevention.</p><p><strong>Recent findings: </strong>The risk of developing OA varies according to the geographic localization of the worker, the type of industry and the type of sensitizing agents. New findings have been reported for several known sensitizing agents, such as isocyanates, seafood & cleaning agents, and their related industries, such as hairdressing salons and schools. Moreover, a few new sensitizing agents, such as cannabis, have been identified in the past few years. The prognosis of OA seems worse than that of nonwork-related asthma. It is mainly determined by the duration and the level of exposure. Primary prevention is crucial to reduce the number of new cases of OA. Complete avoidance of exposure to the causal agent remains the optimal treatment of sensitizer-induced OA.</p><p><strong>Summary: </strong>Improving our knowledge regarding OA and its causative agents is key to enable an early recognition of this condition and improve its prognosis. Further research is still needed to improve primary prevention.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"281-286"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139982626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: The evolving landscape of asthma: recent advances and challenges. 社论：哮喘的演变：最新进展与挑战。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-26 DOI: 10.1097/MCP.0000000000001069
Sandhya Khurana, Christian Taube
{"title":"Editorial: The evolving landscape of asthma: recent advances and challenges.","authors":"Sandhya Khurana, Christian Taube","doi":"10.1097/MCP.0000000000001069","DOIUrl":"10.1097/MCP.0000000000001069","url":null,"abstract":"","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":"30 3","pages":"266-267"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keeping global focus on the many challenges of respiratory tract infections. 让全球关注呼吸道感染的诸多挑战。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-26 DOI: 10.1097/MCP.0000000000001066
Alimuddin Zumla, David S Hui
{"title":"Keeping global focus on the many challenges of respiratory tract infections.","authors":"Alimuddin Zumla, David S Hui","doi":"10.1097/MCP.0000000000001066","DOIUrl":"10.1097/MCP.0000000000001066","url":null,"abstract":"","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":"30 3","pages":"201-203"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung infections due to emerging fungal pathogens. 新出现的真菌病原体导致的肺部感染。
IF 3.3 3区 医学
Current Opinion in Pulmonary Medicine Pub Date : 2024-05-01 Epub Date: 2024-02-15 DOI: 10.1097/MCP.0000000000001059
Francisco J Machiavello Roman, Lauren Pischel, Marwan M Azar
{"title":"Lung infections due to emerging fungal pathogens.","authors":"Francisco J Machiavello Roman, Lauren Pischel, Marwan M Azar","doi":"10.1097/MCP.0000000000001059","DOIUrl":"10.1097/MCP.0000000000001059","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights the epidemiology, pathogenesis and clinical management of pulmonary infections caused by emerging fungal organisms.</p><p><strong>Recent findings: </strong>Emerging fungal infections have arisen as a result of population and environmental changes. An enlarging pool of immunocompromised hosts on triazole antifungal prophylaxis has led to an increased incidence of non- Aspergillus molds, such as Fusarium , Scedosporium and Lomentospora spp. Advances in diagnostic capabilities led to the identification of the Emergomyces genus and non- dermatitidis Blastomyces species, which have a significant disease burden in Africa and the Middle East. Climate change has contributed to changing the distribution of previously confined endemic mycoses, like coccidioidomycosis and talaromycosis. These emerging organisms pose important diagnostic and therapeutic challenges.</p><p><strong>Summary: </strong>Newly recognized pathogenic fungi and established endemic mycoses with expanding geographic boundaries have become important agents of pulmonary disease. There is a dearth of clinical evidence on the appropriate management of these infections.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"258-265"},"PeriodicalIF":3.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信